Recombinant human cystatin C and two of its mutants were expressed in Esche
richia coli. The recombinant inhibitor was found to be identical to authent
ic cystatin C as judged by isoelectric focusing (pI 9.2) and kinetics of in
hibition of papain and human cathepsins B, H and L. N-terminal truncation o
f 8 residues resulted in a decrease of isoelectric point (pI 7.8), but the
inhibitory properties were similar to those of recombinant cystatin C, sugg
esting that Leu9 is a critical residue for the inhibition. The mutation of
Trp106 to Ser, however, resulted in a decreased affinity of the inhibitor f
or the enzymes tested, with the largest effect on cathepsin B inhibition (s
imilar to 100-fold increase in K-i).